ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
Recruiting · NCT05071937 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneum cancer | Recruiting | Phase 2 | 2026-06-18 | NCT05071937 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alexander B Olawaiye, MD | 3 |
| Pfizer | 431 |
| Zenith Epigenetics | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Pittsburgh Medical Center | Pittsburgh | United States | 127 |